Skip to Main Content
I'm looking for

Our leadership team

Our Board and operational leadership team drive the company forward.

Richard Twomey, Mölnlycke CEO

Richard Twomey

Welshman Richard Twomey joined the company in February of 2014, taking over the role of CEO on 1 April. He was previously International Vice President of the California-based orthodontics company Align Technology and has also held a number of senior positions within divisions of Johnson & Johnson and as President of DePuy, International Ltd.

Martin Lexa, Mölnlycke Execute Vice President, Human Resources & Corporate Communications

Martin Lexa

Martin Lexa is a German national, who before he joined the company held a position as Head HR EMEA at Alcon, a Novartis company. Martin has extensive and broad-based experience in mature and emerging markets for Novartis, Medtronic, Bristol-Myers Squibb and others.

Stefan Fristedt, Mölnlycke Executive Vice President and CFO

Stefan Fristedt

Stefan is a Swedish national and joined the company and the Executive leadership team in December 2016. With a solid background in finance, and a decade within the med-tech industry, he has held senior positions at Getinge and the listed environmental technology group Nederman. Over the years he has gained a broad international experience through assignments in the US, Germany and Switzerland.

Eric De Kesel, Mölnlycker Executive Vice President, Operations

Eric De Kesel

Eric has been with the company since 2002 and has held roles as GM of our factory in Waremme, Belgium, as well as heading up various business units within our commercial organisation. Before taking on his current role, he was President of the Surgical Division.

Barry McBride, Executive Vice President, Research & Development

Barry McBride

Barry joined the company in November 2014, after many years' experience in senior roles in healthcare companies around the world – including 20 years at Teleflex, most recently as Chief Technology Officer with global responsibility for Research and Development. He has also acted as Industrial Mentor to the School of Pharmacy at Queens University, Belfast, and was Executive Director, International at Invest, Northern Ireland.

Cathy Dalene

Cathy is a Norwegian national. She joined the company in 2016, and the Executive management team in June 2018. Before taking on her current role, she held roles as VP Global Marketing and Global Franchise Lead, Prevention.

Cathy has many years of experience from the medical device industry, holding several leadership roles across various Johnson & Johnson operating companies.


Gavin Wood

Gavin is a Canadian national. He joined the company in 2015 and the Executive management team in June 2018. Before taking on his current role he held roles as VP Global Strategic Marketing & Market Access and most recently as VP Corporate Strategy & Business Development

Gavin has many years of experience within the medical device industry, including several leadership positions with Johnson & Johnson.

Anders Andersson, Mölnlycke Executive Vice President, OR Solutions

Anders Andersson

Anders is responsible for our focused OR (Operating Room) Solutions organization within the Mölnlycke Procedure Trays, staff clothing and drapes product ranges. Anders has been with the company since 2000. During the years with Mölnlycke he has held various senior roles in Operations, Commercial and R&D. Before taking on his current role, he was Vice President of Global Manufacturing. 

As of October 2017 Anders has been appointed EVP OR Solutions and is a member of the Executive Leadership team.

Our Board

Mölnlycke Board of directors:  Gunnar Brock, Fred Cohen, Christer Eriksson, John Hepburn, Clare Hollingworth, Johan Malmqvist, Richard Twomey and Lennart Johannson Our board

Our Board has seven directors – Gunnar Brock, Fred Cohen, Christer Eriksson, John Hepburn, Clare Hollingworth, Johan Malmqvist and our CEO Richard Twomey – plus one member from Investor AB, Lennart Johansson. Five are independent members. Chairman of the Board Gunnar Brock (one of the five independent Board members) is also from Investor. 






Contact us
Select your market

Select your market